Recap: Experts Discuss NRG1 Fusions as Key Oncogenic Drivers for Certain Patients With Lung Cancer
D. Ross Camidge, MD, PhD, and Alexander I. Spira, MD, PhD, discussed the use of NRG1 fusions as being a driver for patients with lung cancer.
Recap: Prognostic Potential of ctDNA for Oligometastatic Colorectal Cancer
Richard Kim, MD, and Lilliana Bustamante, MD, discuss the potnetial for using ctDNA to treat patients with oligometastatic colorectal cancer.
Recap: Recommendations for PARP Inhibitor Use in Prostate Cancer
A. Oliver Sartor, MD, discussen treatment options for PARP inhibitor use in patients with prostate cancer.
Recap: Targeted Therapies for EGFR Exon 20 Insertion-Positive NSCLC
Zofia Piotrowska, MD, discusses potential therapies for patients with EGFR exon 20 insertion-positive non–small cell lung cancer.
Recap: The Shifting Treatment Paradigmfor Advanced Renal Cell Carcinoma
A panel of experts reflect on how to treat patients with advanced renal cell carcinoma by reviewing clinical trial data and discussing patient cases.
Recap: Experts Review Management of Chronic GVHD
Recommendations for treating patients with steroid-refractory chronic GVHD based on evidence demonstrated by the REACH3 trial.
Recap: Optimizing Therapy in Frontline Multiple Myeloma Not Eligible for Transplant
A panel of experts discuss strategies for optimizing first-line therapy for transplant-ineligible patients with newly diagnosed multiple myeloma.
Optimizing Therapy in Frontline Multiple Myeloma Not Eligible for Transplant
Experts in the multiple myeloma field discuss which front-line therapy is best for patients who are treatment ineligible.
2 Clarke Drive Cranbury, NJ 08512